Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).

NCT06736288 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Infection
Lower Respiratory Tract Infection (LRTI)

Interventions

DRUG: BUCCALIN®
OTHER: Placebo

Sponsor

Laboratorio Farmaceutico SIT srl